Ventas Inc. (VTR)
NYSE: VTR
· Real-Time Price · USD
65.14
-0.35 (-0.53%)
At close: May 20, 2025, 1:30 PM
Ventas Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2020 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senior Living Operations Revenue | 3.37B | 869.71M | 2.65B | 695.26M | 737.8M | 1.84B | 1.85B | 1.81B | 974.94M | 880.35M | 1.23B | 654.79M |
| Senior Living Operations Revenue Growth | +287.81% | -67.20% | +281.42% | -5.76% | -59.97% | -0.22% | +1.99% | +85.78% | +10.75% | -28.40% | +87.77% | n/a |
| Outpatient Medical And Research Portfolio Revenue | 877.59M | 2.96B | 598.15M | n/a | n/a | 844.71M | 850.75M | 784.23M | 1.55B | 1.41B | 835.66M | 873.31M |
| Outpatient Medical And Research Portfolio Revenue Growth | -70.34% | +394.73% | n/a | n/a | n/a | -0.71% | +8.48% | -49.50% | +10.45% | +68.25% | -4.31% | n/a |
| Triple Net Leased Properties Revenue | 622.05M | 619.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Triple Net Leased Properties Revenue Growth | +0.46% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 53.15M | 41.43M | 35.09M | 37.73M | 48.74M | 36.38M | 33.3M | 34.4M | 44.8M | 33.54M | 35.42M | 32.91M | 43M | 28.6M | 30.26M | 30.59M | 40.31M | 29.54M | 34.23M | 29.98M | 42.53M | 41.63M | 40.53M | 43.08M | 40.76M | 38.48M | 39.68M | 36.66M | 37.17M | 34.93M | 33.32M | 33.28M | 33.96M | 31.49M | 31.57M | 32.09M | 31.73M | 27.64M | 32.11M | 33.96M | 34.33M |
| Selling, General, and Administrative Revenue Growth | +28.27% | +18.07% | -6.98% | -22.59% | +33.96% | +9.27% | -3.20% | -23.21% | +33.57% | -5.31% | +7.61% | -23.45% | +50.33% | -5.48% | -1.08% | -24.12% | +36.47% | -13.71% | +14.15% | -29.51% | +2.18% | +2.71% | -5.92% | +5.69% | +5.94% | -3.03% | +8.24% | -1.39% | +6.42% | +4.84% | +0.11% | -2.00% | +7.85% | -0.25% | -1.64% | +1.16% | +14.80% | -13.94% | -5.44% | -1.07% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |